Wordt geladen...
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
BACKGROUND: Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD) may suffer recurrent exacerbations with an increase in volume or purulence of sputum, or both. Personal and healthcare costs associated with exacerbations indicate that therapies that reduce the occurrenc...
Bewaard in:
| Gepubliceerd in: | Cochrane Database Syst Rev |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2019
|
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527426/ https://ncbi.nlm.nih.gov/pubmed/31107966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001287.pub6 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|